We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVT:NYSEnVent Electric plc Analysis

Data as of 2026-06-21 - not real-time

$177.02

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: NVT is trading at $177.02, just below the identified resistance of $179.03 and comfortably above the 20‑day SMA of $167.7 and 50‑day SMA of $157.5, indicating a short‑term bullish bias. However, the 14‑day RSI sits at 62.6 (overbought) and the MACD shows a bearish signal with a negative histogram, suggesting momentum may be waning near the top of the range. Support sits around $153, giving a modest upside of roughly 6% if the stock can break the resistance.
Fundamental backdrop: The company posted 53.5% revenue growth, solid operating margins (~16%), and a healthy free cash flow generation, while maintaining a modest payout ratio (27.5%) and a sustainable dividend yield of 0.47%. Yet valuation is stretched – a trailing P/E of 60 versus an industry average of 31 and a DCF fair value of $37.4 imply the stock is significantly overvalued. Recent material news – the appointment of Nitin Jain and a strategic AI‑data‑center partnership with Siemens/NVIDIA – could catalyze further top‑line expansion, but investors should weigh this against the high valuation and elevated volatility (41.7% 30‑day) and beta (1.68).

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI indicating overbought conditions
  • Bearish MACD divergence
  • Proximity to resistance level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and expanding margins
  • Strategic AI/data‑center partnership driving future demand
  • Analyst consensus of strong‑buy and upward price targets

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained dividend with low payout ratio
  • Long‑term secular growth in data‑center and industrial segments
  • Current valuation premium requiring multiple expansion for upside

Key Metrics & Analysis

Financial Health

Revenue Growth53.50%
Profit Margin11.37%
P/E Ratio60.2
ROE13.00%
ROA6.40%
Debt/Equity44.71
P/B Ratio7.5
Op. Cash Flow$490.2M
Free Cash Flow$209.9M
Industry P/E31.4

Technical Analysis

TrendBullish
RSI62.6
Support$153.01
Resistance$179.03
MA 20$167.72
MA 50$157.52
MA 200$119.83
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair Value$37.41
Target Price$187.67
Upside/Downside6.01%
GradeOvervalued
TypeGrowth
Dividend Yield0.47%

Risk Assessment

Beta1.68
Volatility41.71%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.